Ernexa Therapeutics Inc.
ERNA
$4.27
-$0.03-0.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.01M | -5.51M | -1.50M | -1.24M | -3.14M |
| Total Depreciation and Amortization | 44.00K | 86.00K | 69.00K | 70.00K | 55.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 303.00K | 2.45M | 335.00K | -380.00K | 1.01M |
| Change in Net Operating Assets | -490.00K | 707.00K | -50.00K | 279.00K | -461.00K |
| Cash from Operations | -4.15M | -2.26M | -1.15M | -1.27M | -2.53M |
| Capital Expenditure | -3.00K | -2.00K | -15.00K | -22.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.00K | -2.00K | -15.00K | -22.00K | -- |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.00K | 10.50M | 0.00 | 26.00K | 4.93M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -941.00K | -- | -- | -- |
| Cash from Financing | 6.00K | 9.56M | 0.00 | 26.00K | 4.93M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.15M | 7.29M | -1.16M | -1.27M | 2.40M |